Clinical trial

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

NCT06476509

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention LV232 40mg Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Escitalopram 20 mg Normalized identity: escitalopram 20 MGView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention LV232 60mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention LV232 20mg Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-05-30

PhasePHASE1

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

LV232 40mgDRUG

Escitalopram 20 mgDRUG · verified · RxNorm: escitalopram 20 MG

LV232 60mgDRUG

LV232 20mgDRUG

Sponsors & collaborators

Vigonvita Life Scienceslead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06476509 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.